Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleOMERACT 11

Application of the OMERACT Filter to Measures of Core Outcome Domains in Recent Clinical Studies of Acute Gout

William J. Taylor, David Redden, Nicola Dalbeth, H. Ralph Schumacher, N. Lawrence Edwards, Lee S. Simon, Markus R. John, Margaret N. Essex, Douglas J. Watson, Robert Evans, Keith Rome and Jasvinder A. Singh
The Journal of Rheumatology March 2014, 41 (3) 574-580; DOI: https://doi.org/10.3899/jrheum.131245
William J. Taylor
From the Department of Medicine, University of Otago, Wellington, New Zealand; Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA; Department of Medicine, University of Auckland, Auckland, New Zealand; University of Pennsylvania and Veterans Affairs (VA) Medical Center, Philadelphia, Pennsylvania, USA; Department of Medicine, University of Florida, Gainesville, Florida, USA; SDG LLC, Cambridge, Massachusetts, USA; and Integrated Hospital Care Franchise, Immunology, Novartis Pharma AG, Basel, Switzerland; Pfizer Inc., New York, New York, USA; Epidemiology, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, USA; Clinical Sciences, Regeneron Pharmaceuticals, Tarrytown, New Jersey, USA; Health & Rehabilitation Research Institute and School of Podiatry, Auckland University of Technology, Auckland, New Zealand; and Birmingham VA Medical Center and University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: will.taylor{at}otago.ac.nz
David Redden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicola Dalbeth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Ralph Schumacher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Lawrence Edwards
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lee S. Simon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus R. John
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret N. Essex
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas J. Watson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Evans
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith Rome
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jasvinder A. Singh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Article Information

vol. 41 no. 3 574-580
DOI 
https://doi.org/10.3899/jrheum.131245
PubMed 
24429178

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Published online March 1, 2014.

Article Versions

  • Latest version (January 15, 2014 - 12:30).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2014

Author Information

  1. William J. Taylor⇑,
  2. David Redden,
  3. Nicola Dalbeth,
  4. H. Ralph Schumacher,
  5. N. Lawrence Edwards,
  6. Lee S. Simon,
  7. Markus R. John,
  8. Margaret N. Essex,
  9. Douglas J. Watson,
  10. Robert Evans,
  11. Keith Rome and
  12. Jasvinder A. Singh
  1. From the Department of Medicine, University of Otago, Wellington, New Zealand; Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA; Department of Medicine, University of Auckland, Auckland, New Zealand; University of Pennsylvania and Veterans Affairs (VA) Medical Center, Philadelphia, Pennsylvania, USA; Department of Medicine, University of Florida, Gainesville, Florida, USA; SDG LLC, Cambridge, Massachusetts, USA; and Integrated Hospital Care Franchise, Immunology, Novartis Pharma AG, Basel, Switzerland; Pfizer Inc., New York, New York, USA; Epidemiology, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, USA; Clinical Sciences, Regeneron Pharmaceuticals, Tarrytown, New Jersey, USA; Health & Rehabilitation Research Institute and School of Podiatry, Auckland University of Technology, Auckland, New Zealand; and Birmingham VA Medical Center and University of Alabama at Birmingham, Birmingham, Alabama, USA.
  2. W.J. Taylor, PhD, FRACP, Associate Professor, Department of Medicine, University of Otago; D. Redden, PhD, Associate Professor, Department of Biostatistics, School of Public Health, University of Alabama at Birmingham; N. Dalbeth, MD, FRACP, Associate Professor, Department of Medicine, University of Auckland; H.R. Schumacher, MD, Professor, University of Pennsylvania and VA Medical Center; N.L. Edwards, MD, Professor, Department of Medicine, University of Florida; L.S. Simon, MD, SDG LLC; M.R. John, MD, Global Program Medical Director, Integrated Hospital Care Franchise, Immunology, Novartis Pharma AG; M.N. Essex, PharmD, Senior Medical Director, Pfizer Inc.; D.J. Watson, PhD, FISPE, Epidemiology, Merck Sharp & Dohme Corp.; R. Evans, PharmD, Senior Director, Clinical Sciences, Regeneron Pharmaceuticals; K. Rome, PhD, Professor, Health and Rehabilitation Research Institute and School of Podiatry, Auckland University of Technology; J.A. Singh, MBBS, MPH, Associate Professor, Birmingham VA Medical Center and University of Alabama at Birmingham.
  1. Address correspondence to Prof. Taylor, Department of Medicine, University of Otago, PO Box 7343, Wellington, New Zealand. E-mail: will.taylor{at}otago.ac.nz

Article usage

Article usage: January 2014 to December 2025

AbstractFullPdf
Jan 2014155015
Feb 2014139117
Mar 2014321930
Apr 201465313
May 20143794
Jun 20144125
Jul 20143514
Aug 20142845
Sep 20141546
Oct 20143656
Nov 20141604
Dec 20142817
Jan 20151813
Feb 20152024
Mar 2015251215
Apr 20151411
May 2015922
Jun 20152911
Jul 20151512
Aug 20151413
Sep 2015900
Oct 20151702
Nov 2015702
Dec 20151620
Jan 20161701
Feb 20161112
Mar 20161422
Apr 20161300
May 2016800
Jun 20161420
Jul 20161921
Aug 20162032
Sep 20161422
Oct 20161411
Nov 20162335
Dec 20162900
Jan 20171230
Feb 20171521
Mar 20172012
Apr 20171673
May 20175852
Jun 20171424
Jul 20171594
Aug 20172313
Sep 20171868
Oct 201727311
Nov 20171832
Dec 20171445
Jan 20181201
Feb 20181924
Mar 201823513
Apr 20182649
May 20183147
Jun 20183012
Jul 201832415
Aug 201825716
Sep 20181731
Oct 20181901
Nov 20183965
Dec 201839812
Jan 20193412
Feb 201947515
Mar 201927610
Apr 20192428
May 20191401
Jun 2019903
Jul 20194339
Aug 20193148
Sep 20191804
Oct 20192517
Nov 201931212
Dec 201922312
Jan 20201677
Feb 202031416
Mar 2020173
Apr 202012017
May 2020158
Jun 20201517
Jul 20201819
Aug 20203316
Sep 20205924
Oct 202022313
Nov 2020757
Dec 20205133
Jan 2021137
Feb 202111187
Mar 2021561
Apr 202110112
May 202123128
Jun 2021101111
Jul 2021165
Aug 20210212
Sep 2021493
Oct 202112213
Nov 20211137
Dec 20211136
Jan 2022079
Feb 2022275
Mar 20221652
Apr 20221767
May 2022387
Jun 20225115
Jul 20221116
Aug 2022463
Sep 20224107
Oct 2022287
Nov 2022385
Dec 2022122
Jan 20231297
Feb 2023042
Mar 2023466
Apr 2023199
May 202341218
Jun 2023464
Jul 20234616
Aug 20234411
Sep 20236129
Oct 20231345
Nov 20231105
Dec 202341910
Jan 20243145
Feb 2024596
Mar 202471513
Apr 202461617
May 202412717
Jun 202471515
Jul 202442016
Aug 202432210
Sep 20243216
Oct 20241179
Nov 202471410
Dec 202451817
Jan 202501416
Feb 2025103713
Mar 202521714
Apr 202512418
May 202521010
Jun 2025252720
Jul 202552017
Aug 202591521
Sep 202553128
Oct 2025131916
Nov 2025153016
Dec 2025124222

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 41, Issue 3
1 Mar 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Application of the OMERACT Filter to Measures of Core Outcome Domains in Recent Clinical Studies of Acute Gout
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Application of the OMERACT Filter to Measures of Core Outcome Domains in Recent Clinical Studies of Acute Gout
William J. Taylor, David Redden, Nicola Dalbeth, H. Ralph Schumacher, N. Lawrence Edwards, Lee S. Simon, Markus R. John, Margaret N. Essex, Douglas J. Watson, Robert Evans, Keith Rome, Jasvinder A. Singh
The Journal of Rheumatology Mar 2014, 41 (3) 574-580; DOI: 10.3899/jrheum.131245

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Application of the OMERACT Filter to Measures of Core Outcome Domains in Recent Clinical Studies of Acute Gout
William J. Taylor, David Redden, Nicola Dalbeth, H. Ralph Schumacher, N. Lawrence Edwards, Lee S. Simon, Markus R. John, Margaret N. Essex, Douglas J. Watson, Robert Evans, Keith Rome, Jasvinder A. Singh
The Journal of Rheumatology Mar 2014, 41 (3) 574-580; DOI: 10.3899/jrheum.131245
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgment
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Keywords

GOUT
OUTCOME MEASURES
PSYCHOMETRICS

Related Articles

Cited By...

More in this TOC Section

OMERACT 11

  • Updating the OMERACT Filter: Implications for Imaging and Soluble Biomarkers
  • Updating the OMERACT Filter: Implications for Patient-reported Outcomes
  • Updating the OMERACT Filter: Discrimination and Feasibility
Show more OMERACT 11

Disease-specific Outcomes I

  • Outcome Measures in Acute Gout: A Systematic Literature Review
  • OMERACT Endorsement of Measures of Outcome for Studies of Acute Gout
Show more Disease-specific Outcomes I

Similar Articles

Keywords

  • gout
  • outcome measures
  • PSYCHOMETRICS

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire